1887

Abstract

is a contagious, mastitis-causing pathogen that is highly adapted to survive in the bovine mammary gland. This study used a BALB/c mouse model of mastitis to evaluate leukocyte populations in regional lymph nodes and cytokine expression in the mammary gland involved in the immune response against . It was found that the bacteria replicated efficiently in the mammary gland, peaking after 24 h and increasing by 100-fold. Dissemination of bacteria to systemic organs was observed 6 h after infection. At the same time, a massive infiltration of polymorphonuclear cells and an increase in the inflammatory cytokines interleukin (IL)-1, IL-6 and tumour necrosis factor- were detected in mammary glands, indicating an early inflammatory response. A decrease in the levels of inflammatory cytokines in mammary glands was observed 72 h after infection, accompanied by an increase in the levels of IL-12 and IL-10, which were related to a gradual decrease in bacterial load. An increase in the number of macrophages and B220 lymphocytes and similar increases in both CD4 and CD8 T cells in regional lymph nodes were observed, being most pronounced 5 days after infection. Moreover, increased levels of anti- antibodies in the mammary gland were observed 10 days after infection. Overall, these data suggest that the host exhibits both innate and acquired immune responses in response to mastitis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.007385-0
2009-07-01
2024-04-26
Loading full text...

Full text loading...

/deliver/fulltext/jmm/58/7/951.html?itemId=/content/journal/jmm/10.1099/jmm.0.007385-0&mimeType=html&fmt=ahah

References

  1. Almeida R. A., Patel D., Friton G. M., Oliver S. P. 2007; Intracellular killing of mastitis pathogens by penethamate hydriodide following internalization into mammary epithelial cells. J Vet Pharmacol Ther 30:151–156 [CrossRef]
    [Google Scholar]
  2. Armstrong L., Jordan N., Millar A. 1996; Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF- α ) from human alveolar macrophages and peripheral blood monocytes. Thorax 51:143–149 [CrossRef]
    [Google Scholar]
  3. Bannerman D. D., Paape M. J., Lee J. W., Zhao X., Hope J. C., Rainard P. 2004; Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin Diagn Lab Immunol 11:463–472
    [Google Scholar]
  4. Berry E. A., Hillerton J. E. 2002; The effect of selective dry cow treatment on new intramammary infections. J Dairy Sci 85:112–121 [CrossRef]
    [Google Scholar]
  5. Brouillette E., Malouin F. 2005; The pathogenesis and control of Staphylococcus aureus -induced mastitis: study models in the mouse. Microbes Infect 7:560–568 [CrossRef]
    [Google Scholar]
  6. Brouillette E., Grondin G., Lefebvre C., Talbot B. G., Malouin F. 2004; Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus . Vet Microbiol 101:253–262 [CrossRef]
    [Google Scholar]
  7. Cassatella M. A., Meda L., Bonora S., Ceska M., Constantin G. 1993; Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207–2211 [CrossRef]
    [Google Scholar]
  8. Chandler R. L. 1970; Experimental bacterial mastitis in the mouse. J Med Microbiol 3:273–282 [CrossRef]
    [Google Scholar]
  9. Hertting O., Khalil A., Jaremko G., Chromek M., Li Y. H., Bakhiet M., Bartfai T., Tullus K., Brauner A. 2003; Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1 β -deficient mice. Clin Exp Immunol 131:225–233 [CrossRef]
    [Google Scholar]
  10. Hornef M. W., Wick M. J., Rhen M., Normark S. 2002; Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 3:1033–1040 [CrossRef]
    [Google Scholar]
  11. Keefe G. P. 1997; Streptococcus agalactiae mastitis: a review. Can Vet J 38:429–437
    [Google Scholar]
  12. Keefe G. P., Dohoo I. R., Spangler E. 1997; Herd prevalence and incidence of Streptococcus agalactiae in the dairy industry of Prince Edward Island. J Dairy Sci 80:464–470 [CrossRef]
    [Google Scholar]
  13. Kotwal G. J. 1997; Microorganisms and their interaction with the immune system. J Leukoc Biol 62:415–429
    [Google Scholar]
  14. Leitner G., Yadlin B., Glickman A., Chaffer M., Saran A. 2000; Systemic and local immune response of cows to intramammary infection with Staphylococcus aureus . Res Vet Sci 69:181–184 [CrossRef]
    [Google Scholar]
  15. Logan E. F., Mackie D. P., Meneely D. J. 1984; Immunological features of consecutive intramammary infections with Streptococcus agalactiae in vaccinated and non-vaccinated heifers. Br Vet J 140:535–542 [CrossRef]
    [Google Scholar]
  16. Logan E. F., Mackie D. P., Meneely D. J. 1986; Distribution of antibody in different immunoglobulin classes in experimental Streptococcus agalactiae infection of the bovine udder. Br Vet J 142:358–363 [CrossRef]
    [Google Scholar]
  17. Mackie D. P., Logan E. F. 1986; Changes in immunoglobulin levels in whey during experimental Streptococcus agalactiae mastitis. Res Vet Sci 40:183–188
    [Google Scholar]
  18. Maxie M. G. (editor) 2007 Jubb, Kennedy and Palmer's Pathology of Domestic Animals , 5th edn. Philadelphia: Saunders;
    [Google Scholar]
  19. Merl K., Abdulmawjood A., Lammler C., Zschock M. 2003; Determination of epidemiological relationships of Streptococcus agalactiae isolated from bovine mastitis. FEMS Microbiol Lett 226:87–92 [CrossRef]
    [Google Scholar]
  20. Nakajima Y., Mikami O., Yoshioka M., Motoi Y., Ito T., Ishikawa Y., Fuse M., Nakano K., Yasukawa K. 1997; Elevated levels of tumor necrosis factor-alpha (TNF- α ) and interleukin-6 (IL-6) activities in the sera and milk of cows with naturally occurring coliform mastitis. Res Vet Sci 62:297–298 [CrossRef]
    [Google Scholar]
  21. Notebaert S., Meyer E. 2006; Mouse models to study the pathogenesis and control of bovine mastitis. A review. Vet Q 28:2–13 [CrossRef]
    [Google Scholar]
  22. Rambeaud M., Almeida R. A., Pighetti G. M., Oliver S. P. 2003; Dynamics of leukocytes and cytokines during experimentally induced Streptococcus uberis mastitis. Vet Immunol Immunopathol 96:193–205 [CrossRef]
    [Google Scholar]
  23. Rubens C. E., Smith S., Hulse M., Chi E. Y., van Belle G. 1992; Respiratory epithelial cell invasion by group B streptococci. Infect Immun 60:5157–5163
    [Google Scholar]
  24. Shuster D. E., Kehrli M. E. Jr, Stevens M. G. 1993; Cytokine production during endotoxin-induced mastitis in lactating dairy cows. Am J Vet Res 54:80–85
    [Google Scholar]
  25. Soltys J., Quinn M. T. 1999; Selective recruitment of T-cell subsets to the udder during staphylococcal and streptococcal mastitis: analysis of lymphocyte subsets and adhesion molecule expression. Infect Immun 67:6293–6302
    [Google Scholar]
  26. Spits H., de Waal Malefyt R. 1992; Functional characterization of human IL-10. Int Arch Allergy Immunol 99:8–15 [CrossRef]
    [Google Scholar]
  27. Tavares D., Ferreira P., Vilanova M., Videira A., Arala-Chaves M. 1995; Immunoprotection against systemic candidiasis in mice. Int Immunol 7:785–796 [CrossRef]
    [Google Scholar]
  28. Wilson C. D., Richards M. S. 1980; A survey of mastitis in the British dairy herd. Vet Rec 106:431–435 [CrossRef]
    [Google Scholar]
  29. Yamanaka H., Hisaeda K., Hagiwara K., Kirisawa R., Iwai H. 2000; ELISA for bovine interleukin-1 receptor antagonist and its application to mastitic sera and whey. J Vet Med Sci 62:661–664 [CrossRef]
    [Google Scholar]
  30. Zhu Y., Osterlundh I., Hulten F., Magnusson U. 2004; Tumor necrosis factor- α , interleukin-6, serum amyloid A, haptoglobin, and cortisol concentrations in sows following intramammary inoculation of Escherichia coli . Am J Vet Res 65:1434–1439 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.007385-0
Loading
/content/journal/jmm/10.1099/jmm.0.007385-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error